Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms
Abstract Background Over the years, phytomedicines have been widely used as natural modalities for the treatment and prevention of various diseases by different ethnic groups across the globe. Although, 25% of drugs in the USA contain at least one plant-derived therapeutic compound, currently there...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-02-01
|
| Series: | Future Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43094-023-00465-5 |
| _version_ | 1797865369137840128 |
|---|---|
| author | Rekha Gahtori Ankita H. Tripathi Amrita Kumari Nidhi Negi Ashutosh Paliwal Prabhanshu Tripathi Penny Joshi Ramesh C. Rai Santosh K. Upadhyay |
| author_facet | Rekha Gahtori Ankita H. Tripathi Amrita Kumari Nidhi Negi Ashutosh Paliwal Prabhanshu Tripathi Penny Joshi Ramesh C. Rai Santosh K. Upadhyay |
| author_sort | Rekha Gahtori |
| collection | DOAJ |
| description | Abstract Background Over the years, phytomedicines have been widely used as natural modalities for the treatment and prevention of various diseases by different ethnic groups across the globe. Although, 25% of drugs in the USA contain at least one plant-derived therapeutic compound, currently there is a paucity of plant-derived active medicinal ingredients in the pharmaceutical industry. Scientific evidence-based translation of plant-derived ethnomedicines for their clinical application is an urgent need. The anticancer and associated properties (antioxidative, anti-inflammatory, pro-apoptotic and epithelial-mesenchymal transition (EMT) inhibition) of various plant extracts and phytochemicals have been elucidated earlier. Several of the plant derivatives are already in use under prophylactic/therapeutic settings against cancer and many are being investigated under different phases of clinical trials. Main body The purpose of this study is to systematically comprehend the progress made in the area of prophylactic and therapeutic potential of the anticancerous plant derivatives. Besides, we aim to understand their anticancer potential in terms of specific sub-phenomena, such as anti-oxidative, anti-inflammatory, pro-apoptotic and inhibition of EMT, with an insight of the molecules/pathways associated with them. The study also provides details of classes of anticancer compounds, their plant source(s) and the molecular pathway(s) targeted by them. In addition to the antioxidative and antiproliferative potentials of anticancer plant derivatives, this study emphasizes on their EMT-inhibition potential and other ‘anticancer related’ properties. The EMT is highlighted as a phenomenon of choice for targeting cancer due to its role in the induction of metastasis and drug resistance. Different phytochemicals in pre-clinical or clinical trials, with promising chemopreventive/anticancer activities have been enlisted and the plant compounds showing synergistic anticancer activity in combination with the existing drugs have been discussed. The review also unravels the need of carrying out pan-signalome studies for identifying the cardinal pathways modulated by phytomedicine(s), as in many cases, the molecular pathway(s) has/have been randomly studied. Conclusion This review systematically compiles the studies regarding the impact of various plant derivatives in different cancers and oncogenic processes, as tested in diverse experimental model systems. Availability of more comprehensive information on anticancer phyto-constituents, their relative abundance in crude drugs, pathways/molecules targeted by phytomedicines, their long-term toxicity data and information regarding their safe use under the combinatorial settings, would open greater avenues of their utilization in future against this dreaded disease. Graphical Abstract |
| first_indexed | 2024-04-09T23:08:01Z |
| format | Article |
| id | doaj.art-f6d2b452d78341829ca65149f6ea035b |
| institution | Directory Open Access Journal |
| issn | 2314-7253 |
| language | English |
| last_indexed | 2024-04-09T23:08:01Z |
| publishDate | 2023-02-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Future Journal of Pharmaceutical Sciences |
| spelling | doaj.art-f6d2b452d78341829ca65149f6ea035b2023-03-22T10:38:24ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532023-02-019113010.1186/s43094-023-00465-5Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular termsRekha Gahtori0Ankita H. Tripathi1Amrita Kumari2Nidhi Negi3Ashutosh Paliwal4Prabhanshu Tripathi5Penny Joshi6Ramesh C. Rai7Santosh K. Upadhyay8Department of Biotechnology, Kumaun UniversityDepartment of Biotechnology, Kumaun UniversityDepartment of Biotechnology, Kumaun UniversityDepartment of Chemistry, Kumaun UniversityDepartment of Biotechnology, Kumaun UniversityCSIR-Indian Institute of Toxicology ResearchDepartment of Chemistry, Kumaun UniversityTranslational Health Science and Technology InstituteDepartment of Biotechnology, Kumaun UniversityAbstract Background Over the years, phytomedicines have been widely used as natural modalities for the treatment and prevention of various diseases by different ethnic groups across the globe. Although, 25% of drugs in the USA contain at least one plant-derived therapeutic compound, currently there is a paucity of plant-derived active medicinal ingredients in the pharmaceutical industry. Scientific evidence-based translation of plant-derived ethnomedicines for their clinical application is an urgent need. The anticancer and associated properties (antioxidative, anti-inflammatory, pro-apoptotic and epithelial-mesenchymal transition (EMT) inhibition) of various plant extracts and phytochemicals have been elucidated earlier. Several of the plant derivatives are already in use under prophylactic/therapeutic settings against cancer and many are being investigated under different phases of clinical trials. Main body The purpose of this study is to systematically comprehend the progress made in the area of prophylactic and therapeutic potential of the anticancerous plant derivatives. Besides, we aim to understand their anticancer potential in terms of specific sub-phenomena, such as anti-oxidative, anti-inflammatory, pro-apoptotic and inhibition of EMT, with an insight of the molecules/pathways associated with them. The study also provides details of classes of anticancer compounds, their plant source(s) and the molecular pathway(s) targeted by them. In addition to the antioxidative and antiproliferative potentials of anticancer plant derivatives, this study emphasizes on their EMT-inhibition potential and other ‘anticancer related’ properties. The EMT is highlighted as a phenomenon of choice for targeting cancer due to its role in the induction of metastasis and drug resistance. Different phytochemicals in pre-clinical or clinical trials, with promising chemopreventive/anticancer activities have been enlisted and the plant compounds showing synergistic anticancer activity in combination with the existing drugs have been discussed. The review also unravels the need of carrying out pan-signalome studies for identifying the cardinal pathways modulated by phytomedicine(s), as in many cases, the molecular pathway(s) has/have been randomly studied. Conclusion This review systematically compiles the studies regarding the impact of various plant derivatives in different cancers and oncogenic processes, as tested in diverse experimental model systems. Availability of more comprehensive information on anticancer phyto-constituents, their relative abundance in crude drugs, pathways/molecules targeted by phytomedicines, their long-term toxicity data and information regarding their safe use under the combinatorial settings, would open greater avenues of their utilization in future against this dreaded disease. Graphical Abstracthttps://doi.org/10.1186/s43094-023-00465-5PhytomedicineChemo-preventionAnticancerEpithelial to mesenchymal transitionMetastasisDrug-resistance |
| spellingShingle | Rekha Gahtori Ankita H. Tripathi Amrita Kumari Nidhi Negi Ashutosh Paliwal Prabhanshu Tripathi Penny Joshi Ramesh C. Rai Santosh K. Upadhyay Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms Future Journal of Pharmaceutical Sciences Phytomedicine Chemo-prevention Anticancer Epithelial to mesenchymal transition Metastasis Drug-resistance |
| title | Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms |
| title_full | Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms |
| title_fullStr | Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms |
| title_full_unstemmed | Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms |
| title_short | Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms |
| title_sort | anticancer plant derivatives deciphering their oncopreventive and therapeutic potential in molecular terms |
| topic | Phytomedicine Chemo-prevention Anticancer Epithelial to mesenchymal transition Metastasis Drug-resistance |
| url | https://doi.org/10.1186/s43094-023-00465-5 |
| work_keys_str_mv | AT rekhagahtori anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT ankitahtripathi anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT amritakumari anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT nidhinegi anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT ashutoshpaliwal anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT prabhanshutripathi anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT pennyjoshi anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT rameshcrai anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms AT santoshkupadhyay anticancerplantderivativesdecipheringtheironcopreventiveandtherapeuticpotentialinmolecularterms |